drugset / Trial / NCT05158933
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Ovarian Failure
NaSingle-groupOpen-labelTreatment
Summary
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Ovarian Failure
Timeline
- Start
- 2025-04-03
- Primary completion
- 2025-04-03
- Completion
- 2025-04-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AlloRx | Cell therapy | 1e+06 cells/kg | Intravenous |
| Subject | AlloRx | Cell therapy | 2.5e+07 cells | Intravenous |
| Subject | AlloRx | Cell therapy | 1e+08 cells | Intravenous |